-
1
-
-
0016772223
-
Protected environment and intestinal decontamination in acute leukemia
-
Klastersky J, Hensgens C, Debusscher L. Protected environment and intestinal decontamination in acute leukemia. Acta Clin Belg 1975;30:327-32.
-
(1975)
Acta Clin Belg
, vol.30
, pp. 327-332
-
-
Klastersky, J.1
Hensgens, C.2
Debusscher, L.3
-
2
-
-
0016293860
-
Oral dose and faecal concentration of antibiotics during an-tibiotic decontamination in mice and in a patient
-
van der Waaij D, Berghuis-de Vries JM, Korthals Altes C. Oral dose and faecal concentration of antibiotics during an-tibiotic decontamination in mice and in a patient. J Hyg (Lond) 1974;73:197-203.
-
(1974)
J Hyg (Lond)
, vol.73
, pp. 197-203
-
-
Van Der Waaij, D.1
Berghuis-de Vries, J.M.2
Korthals Altes, C.3
-
3
-
-
0021063528
-
A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract
-
Stoutenbeek CP, Van Saene HK, Miranda DR, Zandstra DF. A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract. Acta Anaesthesiol Belg 1983;34:209-21.
-
(1983)
Acta Anaesthesiol Belg
, vol.34
, pp. 209-221
-
-
Stoutenbeek, C.P.1
Van Saene, H.K.2
Miranda, D.R.3
Zandstra, D.F.4
-
4
-
-
84898002266
-
SuDDICU Collaboration: Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: Systematic review and network meta-analysis
-
Price R, MacLennan G, Glen J, SuDDICU Collaboration: Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ 2014;348:g2197.
-
(2014)
BMJ
, vol.348
, pp. g2197
-
-
Price, R.1
MacLennan, G.2
Glen, J.3
-
5
-
-
79958783213
-
Selective digestive decontamination. Why are intensivists more "resistant" than microorganisms?
-
Silvestri L, Petros AJ, De La Cal MA, Visintin S. Selective digestive decontamination. Why are intensivists more "resistant" than microorganisms? Minerva Anestesiol 2011;77: 658-9.
-
(2011)
Minerva Anestesiol
, vol.77
, pp. 658-659
-
-
Silvestri, L.1
Petros, A.J.2
De La Cal, M.A.3
Visintin, S.4
-
6
-
-
84937853994
-
Use of selective digestive tract decontamination in European intensive cares: The ifs and whys
-
Reis Miranda D, Citerio G, Perner A, Dimopoulos G, Torres A, Hoes A et al. Use of selective digestive tract decontamination in European intensive cares: the ifs and whys. Minerva Anestesiol 2015;81:734-42.
-
(2015)
Minerva Anestesiol
, vol.81
, pp. 734-742
-
-
Reis Miranda, D.1
Citerio, G.2
Perner, A.3
Dimopoulos, G.4
Torres, A.5
Hoes, A.6
-
7
-
-
13844254907
-
ESAC Project Group: Outpatient antibiotic use in Europe and association with resistance: A cross-national database study
-
Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.
-
(2005)
Lancet
, vol.365
, pp. 579-587
-
-
Goossens, H.1
Ferech, M.2
Vander Stichele, R.3
Elseviers, M.4
-
8
-
-
0141537234
-
Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: A randomised controlled trial
-
de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003;362:1011-6.
-
(2003)
Lancet
, vol.362
, pp. 1011-1016
-
-
De Jonge, E.1
Schultz, M.J.2
Spanjaard, L.3
Bossuyt, P.M.4
Vroom, M.B.5
Dankert, J.6
-
9
-
-
58249094505
-
Decontamination of the digestive tract and oropharynx in ICU patients
-
de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360:20-31.
-
(2009)
N Engl J Med
, vol.360
, pp. 20-31
-
-
De Smet, A.M.1
Kluytmans, J.A.2
Cooper, B.S.3
Mascini, E.M.4
Benus, R.F.5
Van Der Werf, T.S.6
-
10
-
-
84897463412
-
Redefining the gut as the motor of critical illness
-
Mittal R, Coopersmith CM. Redefining the gut as the motor of critical illness. Trends Mol Med 2014;20:214-23.
-
(2014)
Trends Mol Med
, vol.20
, pp. 214-223
-
-
Mittal, R.1
Coopersmith, C.M.2
-
11
-
-
84897438156
-
Obesity and cancer: A gut microbial connection
-
Ohtani N, Yoshimoto S, Hara E. Obesity and cancer: a gut microbial connection. Cancer Res 2014;74:1885-9.
-
(2014)
Cancer Res
, vol.74
, pp. 1885-1889
-
-
Ohtani, N.1
Yoshimoto, S.2
Hara, E.3
-
12
-
-
84905586295
-
Microbiota and diabetes: An evolving relationship
-
Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut 2014;63:1513-21.
-
(2014)
Gut
, vol.63
, pp. 1513-1521
-
-
Tilg, H.1
Moschen, A.R.2
-
13
-
-
84891473723
-
Human gut microbiome and risk for colorectal cancer
-
Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 2013;105:1907-11.
-
(2013)
J Natl Cancer Inst
, vol.105
, pp. 1907-1911
-
-
Ahn, J.1
Sinha, R.2
Pei, Z.3
Dominianni, C.4
Wu, J.5
Shi, J.6
-
14
-
-
84908608590
-
The gut microbiota, bacterial metabolites and colorectal cancer
-
Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014;12:661-72.
-
(2014)
Nat Rev Microbiol
, vol.12
, pp. 661-672
-
-
Louis, P.1
Hold, G.L.2
Flint, H.J.3
-
15
-
-
84927668122
-
Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus
-
Allin KH, Nielsen T, Pedersen O. Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus. Eur J Endocrinol 2015;172:R167-77.
-
(2015)
Eur J Endocrinol
, vol.172
, pp. R167-R177
-
-
Allin, K.H.1
Nielsen, T.2
Pedersen, O.3
-
16
-
-
84906967938
-
Gut microbiota in cirrhotic liver transplant candidates
-
Grąt M, Hołówko W, Gałecka M, Grąt K, Szachtaz P, Lewandowsk Z et al. Gut microbiota in cirrhotic liver transplant candidates. Hepatogastroenterology 2014;61:1661-7.
-
(2014)
Hepatogastroenterology
, vol.61
, pp. 1661-1667
-
-
Grąt, M.1
Hołówko, W.2
Gałecka, M.3
Grąt, K.4
Szachtaz, P.5
Lewandowsk, Z.6
-
17
-
-
84912544732
-
Gut microbiota and metabolic syndrome
-
Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014;20:16079-94.
-
(2014)
World J Gastroenterol
, vol.20
, pp. 16079-16094
-
-
Festi, D.1
Schiumerini, R.2
Eusebi, L.H.3
Marasco, G.4
Taddia, M.5
Colecchia, A.6
-
19
-
-
22144495054
-
Colonic microbiota signatures across five northern european countries
-
Lay C, Rigottier-Gois L, Holmstrøm K, Rajilic M, Vaughan EE, de Vos WM et al. Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol 2005;71:4153-5.
-
(2005)
Appl Environ Microbiol
, vol.71
, pp. 4153-4155
-
-
Lay, C.1
Rigottier-Gois, L.2
Holmstrøm, K.3
Rajilic, M.4
Vaughan, E.E.5
De Vos, W.M.6
-
20
-
-
77956024761
-
Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients
-
Benus RF, Harmsen HJ, Welling GW, Spanjersberg R, Zijlstra JG, Degener JE et al. Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients. Intensive Care Med 2010;36:1394-402.
-
(2010)
Intensive Care Med
, vol.36
, pp. 1394-1402
-
-
Benus, R.F.1
Harmsen, H.J.2
Welling, G.W.3
Spanjersberg, R.4
Zijlstra, J.G.5
Degener, J.E.6
-
21
-
-
0033635312
-
Opinion: The clinical use of selective digestive decontamination
-
Kollef MH. Opinion: the clinical use of selective digestive decontamination. Crit Care 2000;4:327-32.
-
(2000)
Crit Care
, vol.4
, pp. 327-332
-
-
Kollef, M.H.1
-
22
-
-
84904565544
-
Effects of selective digestive decontamination (SDD) on the gut resistome
-
Buelow E, Gonzalez TB, Versluis D, Oostdijk EA, Ogilvie LA, van Mourik MS et al. Effects of selective digestive decontamination (SDD) on the gut resistome. J Antimicrob Chemother 2014;69:2215-23.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 2215-2223
-
-
Buelow, E.1
Gonzalez, T.B.2
Versluis, D.3
Oostdijk, E.A.4
Ogilvie, L.A.5
Van Mourik, M.S.6
-
23
-
-
84907698058
-
Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: A randomized clinical trial
-
Oostdijk EA, Kesecioglu J, Schultz MJ, Visser CE, de Jonge E, van Essen EH et al. Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial. JAMA 2014;312:1429-37.
-
(2014)
JAMA
, vol.312
, pp. 1429-1437
-
-
Oostdijk, E.A.1
Kesecioglu, J.2
Schultz, M.J.3
Visser, C.E.4
De Jonge, E.5
Van Essen, E.H.6
-
24
-
-
84880147971
-
Dutch SOD-SDD trialists group: Effects of decontamination of the digestive tract and oropharynx in intensive care unit patients on 1-year survival
-
Oostdijk EA, de Smet AM, Bonten MJ, Dutch SOD-SDD trialists group: Effects of decontamination of the digestive tract and oropharynx in intensive care unit patients on 1-year survival. Am J Respir Crit Care Med 2013;188:117-20.
-
(2013)
Am J Respir Crit Care Med
, vol.188
, pp. 117-120
-
-
Oostdijk, E.A.1
De Smet, A.M.2
Bonten, M.J.3
|